1. Home
  2. MRSN vs KOSS Comparison

MRSN vs KOSS Comparison

Compare MRSN & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • KOSS
  • Stock Information
  • Founded
  • MRSN 2001
  • KOSS 1953
  • Country
  • MRSN United States
  • KOSS United States
  • Employees
  • MRSN N/A
  • KOSS N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • MRSN Health Care
  • KOSS Consumer Staples
  • Exchange
  • MRSN Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • MRSN 40.7M
  • KOSS 39.9M
  • IPO Year
  • MRSN 2017
  • KOSS N/A
  • Fundamental
  • Price
  • MRSN $0.32
  • KOSS $4.92
  • Analyst Decision
  • MRSN Buy
  • KOSS
  • Analyst Count
  • MRSN 3
  • KOSS 0
  • Target Price
  • MRSN $4.00
  • KOSS N/A
  • AVG Volume (30 Days)
  • MRSN 2.3M
  • KOSS 23.9K
  • Earning Date
  • MRSN 05-15-2025
  • KOSS 05-08-2025
  • Dividend Yield
  • MRSN N/A
  • KOSS N/A
  • EPS Growth
  • MRSN N/A
  • KOSS N/A
  • EPS
  • MRSN N/A
  • KOSS N/A
  • Revenue
  • MRSN $40,497,000.00
  • KOSS $12,433,361.00
  • Revenue This Year
  • MRSN N/A
  • KOSS N/A
  • Revenue Next Year
  • MRSN N/A
  • KOSS N/A
  • P/E Ratio
  • MRSN N/A
  • KOSS N/A
  • Revenue Growth
  • MRSN 9.88
  • KOSS N/A
  • 52 Week Low
  • MRSN $0.26
  • KOSS $3.12
  • 52 Week High
  • MRSN $3.50
  • KOSS $18.73
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 41.87
  • KOSS 54.53
  • Support Level
  • MRSN $0.35
  • KOSS $4.51
  • Resistance Level
  • MRSN $0.44
  • KOSS $5.07
  • Average True Range (ATR)
  • MRSN 0.04
  • KOSS 0.24
  • MACD
  • MRSN -0.00
  • KOSS 0.05
  • Stochastic Oscillator
  • MRSN 8.48
  • KOSS 78.57

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: